General MedicationsINJECTIONGeneric
CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
CEPHALOTHIN SODIUM
Standard Dose
EQ 40MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 062730 (ANDA).
Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1992-11-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER is listed in Drugs@FDA under application 062730 (ANDA). Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 40MG BASE/ML Sponsor BAXTER HLTHCARE Submission history Latest submission status date: 1992-11-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.